LOCALIZATION OF A VITRONECTIN BINDING REGION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1

被引：0
|
作者：
PADMANABHAN, J [1 ]
SANE, DC [1 ]
机构：
[1] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT INTERNAL MED, WINSTON SALEM, NC 27157 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The PAI-1 binding site for VN was studied using two independent methods. PAI-1 was cleaved by Staph V8 protease, producing 8 frag ments, only 2 of which bound to [I-125]-VN. These fragments were predicted to overlap between residues 91-130. Since PAI-2 has structural homology to PAI-1, but does not bind to vitronectin, chimeras of PAI-1 acid PAI-2 were constructed. Four chimeras, containing PAI-1 residues 1-70, 1-105, 1-114, and 1-167 were constructed and expressed in vitro. PAI-1, PAI-2, and all of the chimeras retained inhibitory activity for t-PA, but only the chimera containing PAI-1 residues 1-167 formed a complex with VN. Together, these results predict that the VN binding site of PAI-1 is between residues 115-130.
引用
收藏
页码：829 / 834
页数：6
相关论文
共 50 条
  • [21] EFFECT OF PEPTIDES ON THE INACTIVATION OF TISSUE PLASMINOGEN-ACTIVATOR BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND ON THE BINDING OF TISSUE PLASMINOGEN-ACTIVATOR TO ENDOTHELIAL-CELLS
    WITTWER, AJ
    SANZO, MA
    THROMBOSIS AND HAEMOSTASIS, 1990, 64 (02) : 270 - 275
  • [22] IMMUNOHISTOCHEMICAL LOCALIZATION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN BREAST-CANCER
    BIANCHI, E
    COHEN, RL
    DAI, A
    THOR, AT
    SHUMAN, MA
    SMITH, HS
    INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (05) : 597 - 603
  • [23] PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN VARIOUS DISEASE STATES
    KRUITHOF, EKO
    GUDINCHET, A
    BACHMANN, F
    THROMBOSIS AND HAEMOSTASIS, 1988, 59 (01) : 7 - 12
  • [24] HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 DEFICIENCY
    FAY, WP
    SHAPIRO, AD
    SHIH, JL
    SCHLEEF, RR
    GINSBURG, D
    CIRCULATION, 1992, 86 (04) : S12 - S12
  • [25] THE PHARMACOKINETICS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN THE RABBIT
    MAYER, EJ
    FUJITA, T
    GARDELL, SJ
    SHEBUSKI, RJ
    REILLY, CF
    BLOOD, 1990, 76 (08) : 1514 - 1520
  • [26] ELUCIDATION OF STRUCTURAL REQUIREMENTS ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 FOR BINDING TO HEPARIN
    EHRLICH, HJ
    GEBBINK, RK
    KEIJER, J
    PANNEKOEK, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (16) : 11606 - 11611
  • [27] DETERMINANTS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY IN TREATED NIDDM AND ITS RELATION TO A POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE
    PANAHLOO, A
    MOHAMEDALI, V
    LANE, A
    GREEN, F
    HUMPHRIES, SE
    YUDKIN, JS
    DIABETES, 1995, 44 (01) : 37 - 42
  • [28] STUDIES OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN RABBITS - PHARMACOKINETICS AND EVIDENCE FOR REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    CIRCULATION RESEARCH, 1990, 67 (05) : 1281 - 1286
  • [29] THE MECHANISM OF THE REACTION BETWEEN HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE PLASMINOGEN-ACTIVATOR
    LINDAHL, TL
    OHLSSON, PI
    WIMAN, B
    BIOCHEMICAL JOURNAL, 1990, 265 (01) : 109 - 113
  • [30] ITO CELLS SYNTHESIZE PLASMINOGEN-ACTIVATOR INHIBITOR-1 - REGULATION BY CORTICOSTEROIDS AND PLASMINOGEN-ACTIVATOR
    KNITTEL, T
    FELLMER, P
    RAMADORI, G
    GASTROENTEROLOGY, 1995, 108 (04) : A1100 - A1100
12345